Buy Narayana Hrudayalaya; target of Rs 260: ICICI Direct
ICICI Direct’s research report on Narayana Hrudayalaya
Q1FY20 revenues grew 19.2% YoY to Rs 777.4 crore (I-direct estimate: Rs 766.5 crore) mainly due to consolidation of Health City Cayman Islands (Cayman) and ramp up in new hospitals. EBITDA margins improved 596 bps YoY to 13.2% (I- direct estimate: 11.9%) due to lower other expenditure and employee cost. EBITDA grew 116.8% YoY to Rs 102.8 crore (I-direct estimate: Rs 91.4 crore). Net profit was at Rs 30.3 crore against net loss of Rs 4.1 crore in Q1FY19 (I-direct estimate: Rs 29.3 crore) mainly due to strong operational performance.
We arrive at an SOTP target price of Rs 260 by valuing the matured hospitals and Cayman Islands at 7x of FY21E EV/EBITDA and other hospitals & other businesses at 1x FY21E EV/sales.
For all recommendations report, click here
Disclaimer: The views and investment tips expressed by investment experts/broking houses/rating agencies on moneycontrol.com are their own, and not that of the website or its management. Moneycontrol.com advises users to check with certified experts before taking any investment decisions.
Subscribe to Moneycontrol Pro and gain access to curated markets data, trading recommendations, equity analysis, investment ideas, insights from market gurus and much more. Get Moneycontrol PRO for 1 year at price of 3 months at 289. Use code FREEDOM.